Global Vasomotor Symptoms of Menopause Treatment Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Menopause is known as the end of the female reproductive period and usually occurs in nearly 85% of women at the age of 40. Menopause leads to a decrease in estrogen and an increase in gonadotropins, leading to a cessation of the menstrual cycle and menstrual flow. These physiological changes lead to vasomotor symptoms. Vasomotor symptoms are a transition between the two phases of menopause and menopause.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Vasomotor Symptoms of Menopause Treatment market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Vasomotor Symptoms of Menopause Treatment market are covered in Chapter 9:
Pherin Pharmaceuticals, Inc.
Pivot Pharmaceuticals Inc
Euroscreen S.A.
EndoCeutics, Inc.
Amgen Inc.
TherapeuticsMD, Inc.
Mithra Pharmaceuticals S.A.
MenoGeniX, Inc.
Radius Health, Inc.
In Chapter 5 and Chapter 7.3, based on types, the Vasomotor Symptoms of Menopause Treatment market from 2017 to 2027 is primarily split into:
Estetrol
Fezolinetant
FP-101
HBN-2
Others
In Chapter 6 and Chapter 7.4, based on applications, the Vasomotor Symptoms of Menopause Treatment market from 2017 to 2027 covers:
Hospital
Homecare
Clinic
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Vasomotor Symptoms of Menopause Treatment market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Vasomotor Symptoms of Menopause Treatment Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Vasomotor Symptoms of Menopause Treatment Market
1.2 Vasomotor Symptoms of Menopause Treatment Market Segment by Type
1.2.1 Global Vasomotor Symptoms of Menopause Treatment Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Vasomotor Symptoms of Menopause Treatment Market Segment by Application
1.3.1 Vasomotor Symptoms of Menopause Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Vasomotor Symptoms of Menopause Treatment Market, Region Wise (2017-2027)
1.4.1 Global Vasomotor Symptoms of Menopause Treatment Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.3 Europe Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.4 China Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.5 Japan Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.6 India Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.8 Latin America Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.5 Global Market Size of Vasomotor Symptoms of Menopause Treatment (2017-2027)
1.5.1 Global Vasomotor Symptoms of Menopause Treatment Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Vasomotor Symptoms of Menopause Treatment Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Vasomotor Symptoms of Menopause Treatment Market
2 INDUSTRY OUTLOOK
2.1 Vasomotor Symptoms of Menopause Treatment Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Vasomotor Symptoms of Menopause Treatment Market Drivers Analysis
2.4 Vasomotor Symptoms of Menopause Treatment Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Vasomotor Symptoms of Menopause Treatment Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Vasomotor Symptoms of Menopause Treatment Industry Development
3 GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET LANDSCAPE BY PLAYER
3.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Share by Player (2017-2022)
3.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Player (2017-2022)
3.3 Global Vasomotor Symptoms of Menopause Treatment Average Price by Player (2017-2022)
3.4 Global Vasomotor Symptoms of Menopause Treatment Gross Margin by Player (2017-2022)
3.5 Vasomotor Symptoms of Menopause Treatment Market Competitive Situation and Trends
3.5.1 Vasomotor Symptoms of Menopause Treatment Market Concentration Rate
3.5.2 Vasomotor Symptoms of Menopause Treatment Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.5 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.6 China Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.7 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.8 India Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.9 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.10 Latin America Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.11 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
5 GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type (2017-2022)
5.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Vasomotor Symptoms of Menopause Treatment Price by Type (2017-2022)
5.4 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate of Estetrol (2017-2022)
5.4.2 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate of Fezolinetant (2017-2022)
5.4.3 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate of FP-101 (2017-2022)
5.4.4 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate of HBN-2 (2017-2022)
5.4.5 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Global Vasomotor Symptoms of Menopause Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Vasomotor Symptoms of Menopause Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Hospital (2017-2022)
6.3.2 Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Homecare (2017-2022)
6.3.3 Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Clinic (2017-2022)
7 GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET FORECAST (2022-2027)
7.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Vasomotor Symptoms of Menopause Treatment Price and Trend Forecast (2022-2027)
7.2 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate of Estetrol (2022-2027)
7.3.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate of Fezolinetant (2022-2027)
7.3.3 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate of FP-101 (2022-2027)
7.3.4 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate of HBN-2 (2022-2027)
7.3.5 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate of Others (2022-2027)
7.4 Global Vasomotor Symptoms of Menopause Treatment Consumption Forecast by Application (2022-2027)
7.4.1 Global Vasomotor Symptoms of Menopause Treatment Consumption Value and Growth Rate of Hospital(2022-2027)
7.4.2 Global Vasomotor Symptoms of Menopause Treatment Consumption Value and Growth Rate of Homecare(2022-2027)
7.4.3 Global Vasomotor Symptoms of Menopause Treatment Consumption Value and Growth Rate of Clinic(2022-2027)
7.5 Vasomotor Symptoms of Menopause Treatment Market Forecast Under COVID-19
8 VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Vasomotor Symptoms of Menopause Treatment Analysis
8.6 Major Downstream Buyers of Vasomotor Symptoms of Menopause Treatment Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Vasomotor Symptoms of Menopause Treatment Industry
9 PLAYERS PROFILES
9.1 Pherin Pharmaceuticals, Inc.
9.1.1 Pherin Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.1.3 Pherin Pharmaceuticals, Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Pivot Pharmaceuticals Inc
9.2.1 Pivot Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.2.3 Pivot Pharmaceuticals Inc Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Euroscreen S.A.
9.3.1 Euroscreen S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.3.3 Euroscreen S.A. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 EndoCeutics, Inc.
9.4.1 EndoCeutics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.4.3 EndoCeutics, Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Amgen Inc.
9.5.1 Amgen Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.5.3 Amgen Inc. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 TherapeuticsMD, Inc.
9.6.1 TherapeuticsMD, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.6.3 TherapeuticsMD, Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Mithra Pharmaceuticals S.A.
9.7.1 Mithra Pharmaceuticals S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.7.3 Mithra Pharmaceuticals S.A. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 MenoGeniX, Inc.
9.8.1 MenoGeniX, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.8.3 MenoGeniX, Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Radius Health, Inc.
9.9.1 Radius Health, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.9.3 Radius Health, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Vasomotor Symptoms of Menopause Treatment Market
1.2 Vasomotor Symptoms of Menopause Treatment Market Segment by Type
1.2.1 Global Vasomotor Symptoms of Menopause Treatment Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Vasomotor Symptoms of Menopause Treatment Market Segment by Application
1.3.1 Vasomotor Symptoms of Menopause Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Vasomotor Symptoms of Menopause Treatment Market, Region Wise (2017-2027)
1.4.1 Global Vasomotor Symptoms of Menopause Treatment Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.3 Europe Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.4 China Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.5 Japan Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.6 India Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.8 Latin America Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Status and Prospect (2017-2027)
1.5 Global Market Size of Vasomotor Symptoms of Menopause Treatment (2017-2027)
1.5.1 Global Vasomotor Symptoms of Menopause Treatment Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Vasomotor Symptoms of Menopause Treatment Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Vasomotor Symptoms of Menopause Treatment Market
2 INDUSTRY OUTLOOK
2.1 Vasomotor Symptoms of Menopause Treatment Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Vasomotor Symptoms of Menopause Treatment Market Drivers Analysis
2.4 Vasomotor Symptoms of Menopause Treatment Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Vasomotor Symptoms of Menopause Treatment Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Vasomotor Symptoms of Menopause Treatment Industry Development
3 GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET LANDSCAPE BY PLAYER
3.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Share by Player (2017-2022)
3.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Player (2017-2022)
3.3 Global Vasomotor Symptoms of Menopause Treatment Average Price by Player (2017-2022)
3.4 Global Vasomotor Symptoms of Menopause Treatment Gross Margin by Player (2017-2022)
3.5 Vasomotor Symptoms of Menopause Treatment Market Competitive Situation and Trends
3.5.1 Vasomotor Symptoms of Menopause Treatment Market Concentration Rate
3.5.2 Vasomotor Symptoms of Menopause Treatment Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.5 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.6 China Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.7 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.8 India Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.9 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.10 Latin America Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
4.11 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Under COVID-19
5 GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type (2017-2022)
5.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Vasomotor Symptoms of Menopause Treatment Price by Type (2017-2022)
5.4 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate of Estetrol (2017-2022)
5.4.2 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate of Fezolinetant (2017-2022)
5.4.3 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate of FP-101 (2017-2022)
5.4.4 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate of HBN-2 (2017-2022)
5.4.5 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Global Vasomotor Symptoms of Menopause Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Vasomotor Symptoms of Menopause Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Hospital (2017-2022)
6.3.2 Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Homecare (2017-2022)
6.3.3 Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Clinic (2017-2022)
7 GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET FORECAST (2022-2027)
7.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Vasomotor Symptoms of Menopause Treatment Price and Trend Forecast (2022-2027)
7.2 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate of Estetrol (2022-2027)
7.3.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate of Fezolinetant (2022-2027)
7.3.3 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate of FP-101 (2022-2027)
7.3.4 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate of HBN-2 (2022-2027)
7.3.5 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate of Others (2022-2027)
7.4 Global Vasomotor Symptoms of Menopause Treatment Consumption Forecast by Application (2022-2027)
7.4.1 Global Vasomotor Symptoms of Menopause Treatment Consumption Value and Growth Rate of Hospital(2022-2027)
7.4.2 Global Vasomotor Symptoms of Menopause Treatment Consumption Value and Growth Rate of Homecare(2022-2027)
7.4.3 Global Vasomotor Symptoms of Menopause Treatment Consumption Value and Growth Rate of Clinic(2022-2027)
7.5 Vasomotor Symptoms of Menopause Treatment Market Forecast Under COVID-19
8 VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Vasomotor Symptoms of Menopause Treatment Analysis
8.6 Major Downstream Buyers of Vasomotor Symptoms of Menopause Treatment Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Vasomotor Symptoms of Menopause Treatment Industry
9 PLAYERS PROFILES
9.1 Pherin Pharmaceuticals, Inc.
9.1.1 Pherin Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.1.3 Pherin Pharmaceuticals, Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Pivot Pharmaceuticals Inc
9.2.1 Pivot Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.2.3 Pivot Pharmaceuticals Inc Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Euroscreen S.A.
9.3.1 Euroscreen S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.3.3 Euroscreen S.A. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 EndoCeutics, Inc.
9.4.1 EndoCeutics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.4.3 EndoCeutics, Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Amgen Inc.
9.5.1 Amgen Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.5.3 Amgen Inc. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 TherapeuticsMD, Inc.
9.6.1 TherapeuticsMD, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.6.3 TherapeuticsMD, Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Mithra Pharmaceuticals S.A.
9.7.1 Mithra Pharmaceuticals S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.7.3 Mithra Pharmaceuticals S.A. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 MenoGeniX, Inc.
9.8.1 MenoGeniX, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.8.3 MenoGeniX, Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Radius Health, Inc.
9.9.1 Radius Health, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification
9.9.3 Radius Health, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Vasomotor Symptoms of Menopause Treatment Product Picture
Table Global Vasomotor Symptoms of Menopause Treatment Market Sales Volume and CAGR (%) Comparison by Type
Table Vasomotor Symptoms of Menopause Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Vasomotor Symptoms of Menopause Treatment Industry Development
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume by Player (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume Share by Player (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Share by Player in 2021
Table Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Player (2017-2022)
Table Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Player (2017-2022)
Table Vasomotor Symptoms of Menopause Treatment Price by Player (2017-2022)
Table Vasomotor Symptoms of Menopause Treatment Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Region Wise (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share, Region Wise in 2021
Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD), Region Wise (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share, Region Wise in 2021
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume by Type (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2021
Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Type (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type in 2021
Table Vasomotor Symptoms of Menopause Treatment Price by Type (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate of Estetrol (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Estetrol (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate of Fezolinetant (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Fezolinetant (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate of FP-101 (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of FP-101 (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate of HBN-2 (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of HBN-2 (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption by Application (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption Market Share by Application (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption Revenue Market Share by Application (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Hospital (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Homecare (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Clinic (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Price and Trend Forecast (2022-2027)
Figure USA Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Vasomotor Symptoms of Menopause Treatment Market Sales Volume Forecast, by Type
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share Forecast, by Type
Table Global Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) Forecast, by Type
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast, by Type
Table Global Vasomotor Symptoms of Menopause Treatment Price Forecast, by Type
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Estetrol (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Estetrol (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Fezolinetant (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Fezolinetant (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of FP-101 (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of FP-101 (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of HBN-2 (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of HBN-2 (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Vasomotor Symptoms of Menopause Treatment Market Consumption Forecast, by Application
Table Global Vasomotor Symptoms of Menopause Treatment Consumption Market Share Forecast, by Application
Table Global Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) Forecast, by Application
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast, by Application
Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Value (Million USD) and Growth Rate of Homecare (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Value (Million USD) and Growth Rate of Clinic (2022-2027)
Figure Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Pherin Pharmaceuticals, Inc. Profile
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Pherin Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Pivot Pharmaceuticals Inc Profile
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Pivot Pharmaceuticals Inc Revenue (Million USD) Market Share 2017-2022
Table Euroscreen S.A. Profile
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Euroscreen S.A. Revenue (Million USD) Market Share 2017-2022
Table EndoCeutics, Inc. Profile
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure EndoCeutics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Amgen Inc. Profile
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Amgen Inc. Revenue (Million USD) Market Share 2017-2022
Table TherapeuticsMD, Inc. Profile
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure TherapeuticsMD, Inc. Revenue (Million USD) Market Share 2017-2022
Table Mithra Pharmaceuticals S.A. Profile
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Mithra Pharmaceuticals S.A. Revenue (Million USD) Market Share 2017-2022
Table MenoGeniX, Inc. Profile
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure MenoGeniX, Inc. Revenue (Million USD) Market Share 2017-2022
Table Radius Health, Inc. Profile
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Radius Health, Inc. Revenue (Million USD) Market Share 2017-2022
Figure Vasomotor Symptoms of Menopause Treatment Product Picture
Table Global Vasomotor Symptoms of Menopause Treatment Market Sales Volume and CAGR (%) Comparison by Type
Table Vasomotor Symptoms of Menopause Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Vasomotor Symptoms of Menopause Treatment Industry Development
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume by Player (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume Share by Player (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Share by Player in 2021
Table Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Player (2017-2022)
Table Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Player (2017-2022)
Table Vasomotor Symptoms of Menopause Treatment Price by Player (2017-2022)
Table Vasomotor Symptoms of Menopause Treatment Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Region Wise (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share, Region Wise in 2021
Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD), Region Wise (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share, Region Wise in 2021
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume by Type (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2021
Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Type (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type in 2021
Table Vasomotor Symptoms of Menopause Treatment Price by Type (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate of Estetrol (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Estetrol (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate of Fezolinetant (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Fezolinetant (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate of FP-101 (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of FP-101 (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate of HBN-2 (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of HBN-2 (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption by Application (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption Market Share by Application (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption Revenue Market Share by Application (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Hospital (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Homecare (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate of Clinic (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Price and Trend Forecast (2022-2027)
Figure USA Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Vasomotor Symptoms of Menopause Treatment Market Sales Volume Forecast, by Type
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share Forecast, by Type
Table Global Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) Forecast, by Type
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast, by Type
Table Global Vasomotor Symptoms of Menopause Treatment Price Forecast, by Type
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Estetrol (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Estetrol (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Fezolinetant (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Fezolinetant (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of FP-101 (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of FP-101 (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of HBN-2 (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of HBN-2 (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Vasomotor Symptoms of Menopause Treatment Market Consumption Forecast, by Application
Table Global Vasomotor Symptoms of Menopause Treatment Consumption Market Share Forecast, by Application
Table Global Vasomotor Symptoms of Menopause Treatment Market Revenue (Million USD) Forecast, by Application
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast, by Application
Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Value (Million USD) and Growth Rate of Homecare (2022-2027)
Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Value (Million USD) and Growth Rate of Clinic (2022-2027)
Figure Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Pherin Pharmaceuticals, Inc. Profile
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Pherin Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Pivot Pharmaceuticals Inc Profile
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Pivot Pharmaceuticals Inc Revenue (Million USD) Market Share 2017-2022
Table Euroscreen S.A. Profile
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Euroscreen S.A. Revenue (Million USD) Market Share 2017-2022
Table EndoCeutics, Inc. Profile
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure EndoCeutics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Amgen Inc. Profile
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Amgen Inc. Revenue (Million USD) Market Share 2017-2022
Table TherapeuticsMD, Inc. Profile
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure TherapeuticsMD, Inc. Revenue (Million USD) Market Share 2017-2022
Table Mithra Pharmaceuticals S.A. Profile
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Mithra Pharmaceuticals S.A. Revenue (Million USD) Market Share 2017-2022
Table MenoGeniX, Inc. Profile
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure MenoGeniX, Inc. Revenue (Million USD) Market Share 2017-2022
Table Radius Health, Inc. Profile
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate
Figure Radius Health, Inc. Revenue (Million USD) Market Share 2017-2022
